Sorrento Therapeutics
$2.389876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.46 (+22.77%) Today
-$0.10 (-4.03%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell SRNE and other stocks, options, ETFs, and crypto commission-free!
About SRNE
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. Read More The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
CEO
Employees
310
Headquarters
San Diego, California
Founded
2006
Market Cap
313.72M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
10.18M
High Today
$2.68
Low Today
$1.98
Open Price
$2.00
Volume
27.88M
52 Week High
$5.09
52 Week Low
$1.39
Collections
SRNE Earnings
-$0.88
-$0.59
-$0.29
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 11, After Hours